Jebediah Ledell
Chief Operating Officer at AVEO PHARMACEUTICALS, INC.
Network origin in Jebediah Ledell first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
CombinatoRx, Inc.
 CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA
33
| Extinct | Pharmaceuticals: Other | 33 |
| Subsidiary | Pharmaceuticals: Major | 24 | |
| Subsidiary | Medical Specialties | 6 | |
Enzyvant, Inc.
 Enzyvant, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Enzyvant, Inc. develops biopharmaceutical products. The company is based in Cambridge, MA. William T. Symonds has been the CEO of the company since 2022.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA.
1
| Subsidiary | Biotechnology | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jebediah Ledell via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
| VERASTEM, INC. | Biotechnology | Chief Executive Officer Chairman Chief Tech/Sci/R&D Officer Director of Finance/CFO Corporate Officer/Principal | |
| CORREVIO PHARMA CORP. | Pharmaceuticals: Major | Director of Finance/CFO Chairman Chief Executive Officer Chief Executive Officer | |
| KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Director of Finance/CFO Founder Director of Finance/CFO | |
Horizon Discovery Ltd.
 Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree Doctorate Degree | |
| Suffolk University | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| BIOGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer Comptroller/Controller/Auditor | |
| McGill University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Comptroller/Controller/Auditor Corporate Officer/Principal | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Corporate Officer/Principal General Counsel | |
| University of British Columbia | College/University | Doctorate Degree Corporate Officer/Principal | |
| SIGMA-ALDRICH CORPORATION | Wholesale Distributors | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
TARIS BioMedical LLC
 TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology TARIS BioMedical LLC operates as a clinical-stage pharmaceutical company. It specializes in urology, continuous local dosing, bladder diseases, oncology, voiding dysfunction. The company was founded by Robert S. Langer Jr., Christine Bunt, and Michael J. Cima in 2008 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Founder | |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Emory University | College/University | Doctorate Degree Doctorate Degree | |
| Boston University | College/University | Graduate Degree Undergraduate Degree | |
| Yale University | College/University | Graduate Degree Doctorate Degree | |
| EPIRUS BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| University of London | College/University | Undergraduate Degree Doctorate Degree | |
| University of Cambridge | College/University | Doctorate Degree Graduate Degree | |
FORMA Therapeutics, Inc.
 FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | Biotechnology | Chief Operating Officer Chief Executive Officer | |
| EQRX, INC. | Pharmaceuticals: Major | Founder Founder | |
EQRx International, Inc.
 EQRx International, Inc. Pharmaceuticals: MajorHealth Technology EQRx International, Inc. engages in healthcare services. The firm specializes in remaking medicine services. The company was founded by Peter Bach and Sandra Horning on January 12, 2020 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder Founder | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | President Chief Tech/Sci/R&D Officer | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Comptroller/Controller/Auditor | |
IDRx, Inc.
 IDRx, Inc. Miscellaneous Commercial ServicesCommercial Services IDRx, Inc. is a clinical-stage biopharmaceutical company located in an undisclosed location. The American company is dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today's precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy. The company's pipeline programs include small molecule tyrosine kinase inhibitors, and idrx-73, designed to inhibit key genetic drivers and drug-resistant mutations of gastrointestinal stromal tumor (GIST). IDRx was founded in 2021 by Alexis A. Borisy, Nicholas B. Lydon, Ben Auspitz, George D. Demetri, and Robert M. Forrester. Ben Auspitz has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder Founder | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
| University of Oxford | College/University | Doctorate Degree Graduate Degree | |
| The University of Chicago | College/University | Corporate Officer/Principal Undergraduate Degree | |
| University of Illinois | College/University | Director/Board Member Undergraduate Degree | |
| University of Massachusetts | College/University | Undergraduate Degree Graduate Degree | |
| Boston College | College/University | Graduate Degree Undergraduate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| BAXTER INTERNATIONAL INC. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Richardson Capital Ltd.
 Richardson Capital Ltd. Investment ManagersFinance Richardson Capital Ltd. (Richardson Capital) is a private equity arm of Richardson Financial Group Ltd founded in 2003. The firm is headquartered in Winnipeg, Canada. | Investment Managers | Chief Investment Officer Corporate Officer/Principal | |
| EPIZYME, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| COLLEGIUM PHARMACEUTICAL, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO |
Statistics
International
| United States | 40 |
| Canada | 6 |
| United Kingdom | 5 |
| Israel | 2 |
| Germany | 2 |
Sectoral
| Health Technology | 31 |
| Consumer Services | 16 |
| Commercial Services | 4 |
| Distribution Services | 2 |
| Finance | 2 |
Operational
| Director/Board Member | 348 |
| Corporate Officer/Principal | 156 |
| Independent Dir/Board Member | 90 |
| Chairman | 59 |
| Chief Tech/Sci/R&D Officer | 55 |
Most connected contacts
| Insiders | |
|---|---|
| Grahame Cook | 53 |
| Anthony Evnin | 46 |
| Mark Corrigan | 29 |
| Hartley Richardson | 26 |
| Susan Searle | 25 |
| Alexis Borisy | 25 |
| Robert M. Forrester | 25 |
| Michael Kauffman | 24 |
| Patrick J. Fortune | 24 |
| Bill Hunter | 22 |
| Sally Crawford | 22 |
| David Smoller | 21 |
| Ken Bate | 19 |
| Gregory Mayes | 18 |
| Erick Lucera | 18 |
- Stock Market
- Insiders
- Jebediah Ledell
- Company connections
